Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort

BackgroundThe role of stereotactic ablative radiation therapy (SABR) as local treatment option after chemotherapy for locally advanced pancreatic cancer (LAPC) is evolving. However adequate patient selection criteria for SABR in patients with LAPC are lacking.MethodsA prospective institutional datab...

Full description

Bibliographic Details
Main Authors: D. Doppenberg, F. J. Lagerwaard, S. van Dieren, M. R. Meijerink, J. J. van der Vliet, M. G. Besselink, G. van Tienhoven, E. Versteijne, B. J. Slotman, J. W. Wilmink, G. Kazemier, A. M. E. Bruynzeel
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
LAPC
radiotherapy
SABR
MRgRT
patient selection
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1149961/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1149961/full

Similar Items